Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fielding

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Blood Advances|September 3, 2024
Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblastsRichard J Burt, Aditi Dey, Ayse Akarca, et al.
Genes, Chromosomes & Cancer|December 30, 2016
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemiaLisa J Russell, Lisa Jones, Amir Enshaei, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Frontiers in Pharmacology|November 16, 2020
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PROPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Frontiers in Pharmacology|October 5, 2020
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity StudyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcomeLisa J Russell, Amir Enshaei, Lisa Jones, et al.
The Lancet. Haematology|March 31, 2022
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trialDavid I Marks, Laura Clifton-Hadley, Mhairi Copland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Journal of Comparative Effectiveness Research|May 1, 2019
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Blood Advances|September 3, 2024
Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblastsRichard J Burt, Aditi Dey, Ayse Akarca, et al.
Genes, Chromosomes & Cancer|December 30, 2016
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemiaLisa J Russell, Lisa Jones, Amir Enshaei, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Frontiers in Pharmacology|November 16, 2020
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PROPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Frontiers in Pharmacology|October 5, 2020
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity StudyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcomeLisa J Russell, Amir Enshaei, Lisa Jones, et al.
The Lancet. Haematology|March 31, 2022
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trialDavid I Marks, Laura Clifton-Hadley, Mhairi Copland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Journal of Comparative Effectiveness Research|May 1, 2019
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Pageof 17